The progestogen content of combined oral contraceptives and venous thromboembolic risk
نویسندگان
چکیده
منابع مشابه
The progestogen content of combined oral contraceptives and venous thromboembolic risk.
In the linked study (doi:10.1136/bmj.d6423), Lidegaard and colleagues assess the effect of different types of combined oral contraceptive, according to progestogen type and oestrogen dose, on the risk of venous thromboembolism. Over the past four decades, more than 25 epidemiological studies have examined the risk of venous thromboembolism in current users of combined oral contraceptives.All bu...
متن کاملCombined Estrogen–progestogen Contraceptives
Combined hormonal contraceptives consist of an estrogen and a progestogen, and act primarily by preventing ovulation through the inhibition of the follicle-stimulating hormone and luteinizing hormone. The progestogen component also renders the cervical mucus relatively impenetrable to sperm, and reduces the receptivity of the endometrium to implantation (IARC, 2007). A variety of innovations ha...
متن کاملCombined Estrogen–progestogen Contraceptives
Combined hormonal contraceptives consist of an estrogen and a progestogen, and act primarily by preventing ovulation through the inhibition of follicle-stimulating hormone and luteinizing hormone. The progestogen component also renders the cervical mucus relatively impenetrable to sperm and reduces the receptivity of the endometrium to implantation. These mechanisms render combined hormonal con...
متن کاملCombined Estrogen–progestogen Contraceptives
Combined hormonal contraceptives consist of an estrogen and a progestogen, and act primarily by preventing ovulation through the inhibition of the follicle-stimulating hormone and luteinizing hormone. The progestogen component also renders the cervical mucus relatively impenetrable to sperm, and reduces the receptivity of the endometrium to implantation (IARC, 2007). A variety of innovations ha...
متن کاملCombined estrogen-progestogen contraceptives and combined estrogen-progestogen menopausal therapy.
Working Group Members1 Garnet L. Anderson, Women’s Health Initiative, Clinical Coordinating Center, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N, M3-A410, PO Box 19024, Seattle, WA 98109, USA Philippe Autier, Unit of Epidemiology, Prevention and Screening, Jules Bordet Institute, Boulevard de Waterloo 125, Brussels 1000, Belgium Valerie Beral, Cancer Epidemiology Unit, Univers...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 2011
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.d6592